171 related articles for article (PubMed ID: 4348844)
21. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
Hungen KV; Roberts S; Hill DF
Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
[TBL] [Abstract][Full Text] [Related]
22. Evidence for the action of d-lysergic acid diethylamide, mescaline and bufotenine on 5-hydroxytryptamine receptors in umbilical vasculature.
Dyer DC
J Pharmacol Exp Ther; 1974 Feb; 188(2):336-41. PubMed ID: 4359552
[No Abstract] [Full Text] [Related]
23. Some effects of the hallucinogenic drug 2, 5-dimethoxy-4-methyl amphetamine on the metabolism of biogenic amines in the rat brain.
Leonard BE
Psychopharmacologia; 1973 Aug; 32(1):33-49. PubMed ID: 4743235
[No Abstract] [Full Text] [Related]
24. Lisuride- and D-LSD-induced changes of monoamine turnover in the rat brain.
Keller HH; Burkard WP; Pieri L; Bonetti EP; Da Prada M
Adv Biochem Psychopharmacol; 1978; 19():393-6. PubMed ID: 696467
[No Abstract] [Full Text] [Related]
25. Hallucinogenic drugs are partial agonists of the human platelet shape change response: a physiological model of the 5-HT2 receptor.
McClue SJ; Brazell C; Stahl SM
Biol Psychiatry; 1989 Jul; 26(3):297-302. PubMed ID: 2742945
[TBL] [Abstract][Full Text] [Related]
26. Effects of various psychotomimetic agents on the EEG and acetylcholine release from the cerebral cortex of brainstem transected cats.
Domino EF; Bartolini A
Neuropharmacology; 1972 Sep; 11(5):703-13. PubMed ID: 4670597
[No Abstract] [Full Text] [Related]
27. [The drug experience as a biological problem].
Stille G
Schweiz Med Wochenschr; 1971 Sep; 101(35):1257-69. PubMed ID: 4947024
[No Abstract] [Full Text] [Related]
28. The psychopharmacology of hallucinogenic agents.
Freedman DX
Annu Rev Med; 1969; 20():409-18. PubMed ID: 4894506
[No Abstract] [Full Text] [Related]
29. Phencyclidine, lysergic acid diethylamide, and mescaline: cerebral artery spasms and hallucinogenic activity.
Altura BT; Altura BM
Science; 1981 May; 212(4498):1051-2. PubMed ID: 7195070
[TBL] [Abstract][Full Text] [Related]
30. Behavioural effects of some derivatives of amphetamine and LSD and their significance.
Smythies JR; Beaton J; Benington F; Morin RD
Nature; 1970 May; 226(5246):644-5. PubMed ID: 5444927
[No Abstract] [Full Text] [Related]
31. Electrically stimulated release of norepinephrine-H3 and serotonin-H3 from mammalian brain slices: a model for studying the effects of drugs on putative central neurotransmitters.
Katz RI; Chase TN; Koplin IJ
Trans Am Neurol Assoc; 1969; 94():284-6. PubMed ID: 4313963
[No Abstract] [Full Text] [Related]
32. Anorexia and hyperphagia produced by five pharmacologic classes of hallucinogens.
Vaupel DB; Morton EC
Pharmacol Biochem Behav; 1982 Sep; 17(3):539-45. PubMed ID: 6292959
[TBL] [Abstract][Full Text] [Related]
33. [REVIEW OF PSYCHODYSLEPTICS: I. CLASSIFICATION OF PSYCHODYSLEPTICS].
RAJOTTE P
Can Med Assoc J; 1964 Aug; 91(6):293-300. PubMed ID: 14184040
[TBL] [Abstract][Full Text] [Related]
34. The role of central serotonergic mechanisms on head-twitch and backward locomotion induced by hallucinogenic drugs.
Yamamoto T; Ueki S
Pharmacol Biochem Behav; 1981 Jan; 14(1):89-95. PubMed ID: 6258178
[TBL] [Abstract][Full Text] [Related]
35. The effects of hallucinogenic drugs on maze exploration in the rat over a 24 hour period.
Davies JA; Redfern PH
Br J Pharmacol; 1973 Sep; 49(1):121-7. PubMed ID: 4787520
[TBL] [Abstract][Full Text] [Related]
36. The relative effectiveness of several hallucinogens in disrupting maze performance by rats.
Uyeno ET; Mitoma C
Psychopharmacologia; 1969; 16(1):73-80. PubMed ID: 5359329
[No Abstract] [Full Text] [Related]
37. Action of psychotogenic drugs on single midbrain raphe neurons.
Aghajanian GK; Foote WE; Sheard MH
J Pharmacol Exp Ther; 1970 Feb; 171(2):178-87. PubMed ID: 5459056
[No Abstract] [Full Text] [Related]
38. Some aspects of the current drug scene with emphasis on drugs in use by adolescents.
Louria DB
Pediatrics; 1968 Dec; 42(6):904-11. PubMed ID: 5726384
[No Abstract] [Full Text] [Related]
39. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.
Sloviter RS; Drust EG; Damiano BP; Connor JD
J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720
[No Abstract] [Full Text] [Related]
40. Some kinetic and inhibition properties of human brain mitochondrial monoamine oxidase (EC 1.4.3.4).
Jain M; Bakutis E; Gayle T; Lansky P
Neurobiology; 1974; 4(3):180-90. PubMed ID: 4367441
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
